{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:19:10Z","timestamp":1793729950132,"version":"4.6.1"},"reference-count":88,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T00:00:00Z","timestamp":1376438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Cardiovascular Disease"],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:p> The objective of this review is to evaluate the role of fixed-dose triple-combination therapy for the management of hypertension. An assessment of clinical trials showed that half the patients with hypertension have uncontrolled blood pressure (BP), with underlying factors including therapeutic inertia and poor patient adherence. Many patients will require three antihypertensive agents to achieve BP goals, and current guidelines recommend combining drugs with complementary mechanisms of action. Three single-pill triple-combination treatments are available and each includes an agent affecting the renin-angiotensin-aldosterone pathway (either a direct renin inhibitor or an angiotensin II receptor blocker) in combination with a calcium channel blocker and diuretic. These triple-combination therapies consistently demonstrated significantly greater BP reduction relative to the component dual combinations, with BP reductions documented across a range of patient populations. Triple-combination treatments were well tolerated in all clinical trials reviewed. The use of single-pill, triple-combination antihypertensive therapy has been shown to be an effective, well-tolerated, and convenient treatment strategy that can help patients achieve BP control. <\/jats:p>","DOI":"10.1177\/1753944713498638","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T10:48:27Z","timestamp":1376563707000},"page":"246-259","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":17,"title":["Management of hypertension with fixed-dose triple-combination treatments"],"prefix":"10.1177","volume":"7","author":[{"given":"Benjamin J.","family":"Epstein","sequence":"first","affiliation":[{"name":"University of Florida College of Pharmacy, Department of Pharmacotherapy and Translational Research, PO Box 100486, 1600 SW Archer Road, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niren K.","family":"Shah","sequence":"additional","affiliation":[{"name":"East Coast Institute for Research, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Borja-Hart","sequence":"additional","affiliation":[{"name":"Formerly with East Coast Institute for Research, Jacksonville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2013,8,14]]},"reference":[{"key":"bibr1-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-009-1240-1"},{"key":"bibr2-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.08.033"},{"key":"bibr3-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2003.11927893"},{"key":"bibr4-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199006002-00002"},{"key":"bibr5-1753944713498638","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2006.12.3.239"},{"key":"bibr6-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802319364"},{"key":"bibr7-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.6.904"},{"key":"bibr8-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-009-0077-7"},{"key":"bibr9-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.131300"},{"key":"bibr10-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2008.00447.x"},{"key":"bibr11-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"key":"bibr12-1753944713498638","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200828110-00005"},{"key":"bibr13-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1007\/BF03261832"},{"key":"bibr14-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2011.09.003"},{"key":"bibr15-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2002.02045.x"},{"key":"bibr16-1753944713498638","volume-title":"Benicar prescribing information [package insert]","author":"Daiichi Sankyo Inc.","year":"2012"},{"key":"bibr17-1753944713498638","volume-title":"Tribenzor prescribing information [package insert]","author":"Daiichi Sankyo Inc.","year":"2012"},{"key":"bibr18-1753944713498638","first-page":"204","volume":"18","author":"Dickson M.","year":"2008","journal-title":"Ethn Dis"},{"key":"bibr19-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3181d567bd"},{"key":"bibr20-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.650"},{"key":"bibr21-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1177\/1753944709334947"},{"key":"bibr22-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2010.500614"},{"key":"bibr23-1753944713498638","unstructured":"FDA (2011) Guidance for Industry. Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims. Silver Spring, MD: US Food and Drug Administration. [http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm075072.pdf;accessed 5 December 2011]"},{"key":"bibr24-1753944713498638","unstructured":"FDA (2012) FDA Drug Safety Communication: New Warning and Contraindication for Blood Pressure Medicines Containing Aliskiren (Tekturna). Silver Spring, MD: US Food and Drug Administration. [http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm300889.htm;accessed 27 April 2012]"},{"key":"bibr25-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.123455"},{"key":"bibr26-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2011.01.006"},{"key":"bibr27-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.152892"},{"key":"bibr28-1753944713498638","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S4189"},{"key":"bibr29-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.05.010"},{"key":"bibr30-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318282ab8f"},{"key":"bibr31-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2010.00360.x"},{"key":"bibr32-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2010.02.005"},{"key":"bibr33-1753944713498638","doi-asserted-by":"crossref","first-page":"A128","DOI":"10.1111\/j.1751-7176.2010.00397.x","volume":"13","author":"Gradman A.","year":"2011","journal-title":"J Clin Hypertens"},{"key":"bibr34-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.201566"},{"key":"bibr35-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.139816"},{"key":"bibr36-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04311-6"},{"key":"bibr37-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31820a55f5"},{"key":"bibr38-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.724104"},{"key":"bibr39-1753944713498638","first-page":"652","volume":"33","author":"Hess G.","year":"2008","journal-title":"P T"},{"key":"bibr40-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1984.tb03630.x"},{"key":"bibr41-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.72"},{"key":"bibr42-1753944713498638","doi-asserted-by":"publisher","DOI":"10.3317\/jraas.2004.034"},{"key":"bibr43-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.15.2281"},{"key":"bibr44-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2011.00544.x"},{"key":"bibr45-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2003.02676.x"},{"key":"bibr46-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1080\/08037050701395571"},{"key":"bibr47-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16451-9"},{"key":"bibr48-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2011.00588.x"},{"key":"bibr49-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403313301301"},{"key":"bibr50-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2010.115"},{"key":"bibr51-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328356b8ea"},{"key":"bibr52-1753944713498638","unstructured":"Lannett Company Inc. (2007) Hydrochlorothiazide prescribing information [package insert]. Philadelphia, PA: Lannett Company, Inc."},{"key":"bibr53-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11911-8"},{"key":"bibr54-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200305000-00011"},{"key":"bibr55-1753944713498638","first-page":"871","volume":"15","author":"Lynch W.","year":"2009","journal-title":"Am J Manag Care"},{"key":"bibr56-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328333146d"},{"key":"bibr57-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2012.00706.x"},{"key":"bibr58-1753944713498638","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2010.01.2105"},{"key":"bibr59-1753944713498638","unstructured":"NICE (2011) Hypertension: The Clinical Management of Primary Hypertension in Adults. Clinical Guideline 127. London: National Institute for Health and Clinical Excellence. [\nhttp:\/\/www.nice.org.uk\/nicemedia\/live\/13561\/56007\/56007.pdf; accessed 10 October 2011]"},{"key":"bibr60-1753944713498638","first-page":"10","volume":"89","author":"Noll G.","year":"1998","journal-title":"versus"},{"key":"bibr61-1753944713498638","unstructured":"Novartis Pharmaceuticals Corporation (2012a) Amturnide prescribing information [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation."},{"key":"bibr62-1753944713498638","volume-title":"Diovan prescribing information [package insert]","author":"Novartis Pharmaceuticals Corporation","year":"2012"},{"key":"bibr63-1753944713498638","volume-title":"Exforge HCT prescribing information [package insert]","author":"Novartis Pharmaceuticals Corporation","year":"2012"},{"key":"bibr64-1753944713498638","volume-title":"Tekturna prescribing information [package insert]","author":"Novartis Pharmaceuticals Corporation","year":"2012"},{"key":"bibr65-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2005.05293.x"},{"key":"bibr66-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000200702.76436.4b"},{"key":"bibr67-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2010.07.008"},{"key":"bibr68-1753944713498638","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2009.03.1974"},{"key":"bibr69-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2012.11.001"},{"key":"bibr70-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.21.2805"},{"key":"bibr71-1753944713498638","volume-title":"Norvasc prescribing information [package insert]","author":"Pfizer Labs","year":"2011"},{"key":"bibr72-1753944713498638","first-page":"568","volume":"16","author":"Pittman D.","year":"2010","journal-title":"Am J Manag Care"},{"key":"bibr73-1753944713498638","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565002-00002"},{"key":"bibr74-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-007-0464-1"},{"key":"bibr75-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.183885"},{"key":"bibr76-1753944713498638","volume-title":"Pharmacotherapy: A Pathophysiologic Approach","author":"Saseen J.","year":"2011"},{"key":"bibr77-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2011.00550.x"},{"key":"bibr78-1753944713498638","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262030-00003"},{"key":"bibr79-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2004.03902.x"},{"key":"bibr80-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.385"},{"key":"bibr81-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200404000-00029"},{"key":"bibr82-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14739-3"},{"key":"bibr83-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2008.00049.x"},{"key":"bibr84-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.09.038"},{"key":"bibr85-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200311000-00002"},{"key":"bibr86-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.19.2421"},{"key":"bibr87-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.494462"},{"key":"bibr88-1753944713498638","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.534129"}],"container-title":["Therapeutic Advances in Cardiovascular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1753944713498638","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1753944713498638","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1753944713498638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T20:27:27Z","timestamp":1740774447000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1753944713498638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,14]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1177\/1753944713498638"],"URL":"https:\/\/doi.org\/10.1177\/1753944713498638","relation":{},"ISSN":["1753-9447","1753-9455"],"issn-type":[{"value":"1753-9447","type":"print"},{"value":"1753-9455","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,14]]}}}